Trial under way for Alumend's device to treat artery disease

Alumend is conducting an early-stage clinical study in New Zealand to test a device that can be used to help treat patients with peripheral arterial disease. The Sioux Falls, S.D.-based startup aims to refine the technology after the initial trial and advance it to U.S. clinical studies, founding member Ron Utecht said at a biotech conference in Chicago.

View Full Article in:

Argus Leader (Sioux Falls, S.D.) (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
White Plains, NY
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ